Pharmaceutical Published Insights

Published Date : 12 Mar, 2026

IV therapy, also known as IV hydration therapy, is a treatment that boosts the body's immunity by replenishing it with important vitamins, antioxidants, and minerals. The technique, which is similar to drip hydration used in hospitals, helps ease symptoms of dehydrati... View more

Published Date : 12 Mar, 2026

Immunotherapy is a preventive treatment for allergic reactions which are caused by substances such as grass pollens, house dust mites and bee venom. While providing immunotherapy treatment to patients, the dose of the drug is gradually increased to which the person is... View more

Published Date : 11 Mar, 2026

The global Soliris market is estimated to be valued at USD 2,080.2 million in 2026 and is expected to reach USD 982.6 million by 2033, exhibiting a compound annual growth rate (CAGR) of -10.2% from 2026 to 2033. The g... View more

Published Date : 11 Mar, 2026

The Global Allergy Shots Market is estimated to be valued at USD 5.89 Bn in 2026 and is expected to reach USD 9.27 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.7% from 2026 to 2033. The global alle... View more

Published Date : 11 Mar, 2026

The global complementary and alternative medicine market is estimated to be valued at USD 60.95 Bn in 2026 and is expected to reach USD 156.30 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 14.4% from ... View more

Published Date : 11 Mar, 2026

The Global LIPITOR Market is estimated to be valued at USD 1,386.6 Mn in 2026 and is expected to reach USD 937.7 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of -5.4% from 2026 to 2033.... View more

Published Date : 11 Mar, 2026

The Global Aldosterone Synthase Inhibitors Market is estimated to be valued at USD 248.4 Mn in 2026 and is expected to reach USD 723.4 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 16... View more

Published Date : 11 Mar, 2026

The Global Neulasta Market is estimated to be valued at USD 210.3 million in 2026 and is expected to reach USD 95.3 million by 2033, exhibiting a compound annual growth rate (CAGR) of -10.7% from 2026 to 2033. The Global Neulasta Market, a key segment within the biote... View more

Published Date : 11 Mar, 2026

The Global XARELTO Market is estimated to be valued at USD 3.11 Bn in 2026 and is expected to decline to USD 1.77 Bn by 2033, reflecting a negative compound annual growth rate (CAGR) of -7.8% from 2026 to 2033. While ... View more

Published Date : 11 Mar, 2026

The Global Lantus Market is estimated to be valued at USD 2.24 Bn in 2026 and is expected to reach USD 3.37 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.0% from 2026 to 2033. ... View more

Published Date : 11 Mar, 2026

The Global Humira Market is estimated to be valued at USD 4.68 Bn in 2026 and is expected to reach USD 1.20 Bn by 2033, declining at a compound annual growth rate (CAGR) of -17.6% from 2026 to 2033. ... View more

Published Date : 11 Mar, 2026

The global Rituxan market, valued at USD 1,584.3 Mn in 2026, is expected to decline steadily to USD 1,082.1 Mn by 2033, exhibiting a negative compound annual growth rate (CAGR) of -5.3% from 2026 to 2... View more

Published Date : 11 Mar, 2026

The Global Eylea Market is estimated to be valued at USD 969.3 Mn in 2026 and is expected to reach USD 788.8 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of -2.9% from 2026 to 2033. ... View more

Published Date : 11 Mar, 2026

The Global Lucentis Market is estimated to be valued at USD 739.1 Mn in 2026 and is expected to reach USD 64.1 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of -29.5% from 2026 to 2033. The global Lucent... View more

Published Date : 11 Mar, 2026

The Global Remicade Market is estimated to be valued at USD 1,422.0 Mn in 2026 and is expected to reach USD 655.0 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of -10.48% from 2026 to 2033. Despite the prevalence of autoimmune diseases such as rheumatoid... View more

Published Date : 11 Mar, 2026

The Global Loperamide Hydrochloride Market is estimated to be valued at USD 3.73 bn in 2026 and is expected to reach USD 5.59 bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.0% from 2026 to 2033. The global loperamide... View more

Published Date : 11 Mar, 2026

The Global Eye Drops Market is estimated to be valued at USD 7.11 Bn in 2026 and is expected to reach USD 9.61 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 4.4% from 2026 to 2033. The global eye drop... View more

Published Date : 11 Mar, 2026

The Global Melatonin Sleep Gummy Market is estimated to be valued at USD 396.8 Mn in 2026 and is expected to reach USD 707.0 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2026 to 2033. The g... View more